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Abstract: Carcinoid tumor of the ovary is uncommon. We herein report a very rare case of primary ovarian carcinoid 
tumor with aggressive histology and an unusual immunophenotype. A 21-year-old woman presented with a palpable 
abdominal mass. Computed tomographic scan revealed a large, extensively necrotic solid mass in the left ovary. 
The patient underwent a left salpingo-oophorectomy. Grossly, the left adnexa showed a large, vaguely lobulated 
ovarian tumor measuring 22×15×13 cm. Histologically, the tumor had a readily identifiable neuroendocrine growth 
pattern, but some areas showed solid growth pattern associated with mild nuclear pleomorphism and multiple foci 
of punctate necrosis. Furthermore, mitotic figures were recognized in 8 per 10 high-power fields, and a few foci of 
large coagulative tumor necrosis were also noted. In addition, the tumor tissue exhibited uniform, strong nuclear 
β-catenin immunoreactivity, indicating the nuclear accumulation of β-catenin in the individual tumor cells. In sum-
mary, we described the first case of primary ovarian carcinoid tumor with loss of neuroendocrine growth pattern, 
increased mitotic activity and large areas of coagulative tumor necrosis. According to the WHO classification of pul-
monary carcinoid tumor, this case may be classified as “atypical” carcinoid. However, currently, no primary ovarian 
atypical carcinoid exists in the classification system. Due to its rarity, there are no established diagnostic criteria 
and clinical data on patient outcomes for ovarian carcinoid tumors with aggressive histology. Additional reports are 
clearly necessary. We also showed for the first time the nuclear accumulation of β-catenin in carcinoid tumor cells, 
suggestive of a role for β-catenin in the tumorigenesis of ovarian atypical carcinoid tumor or its aggressive histology.
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Introduction
Primary carcinoid tumors of the ovary are rare 
neoplasms. Carcinoid tumors mostly occur in 
the gastrointestinal tract and the lungs [1]. 
Ovarian carcinoid tumors constitute only 0.5% 
of all carcinoid tumors and 0.1% of all ovarian 
neoplasms [2-4]. We recently encountered a 
case of primary ovarian carcinoid tumor with 
aggressive histology including loss of “neuro-
endocrine” growth pattern, frequent mitotic fig-
ures and foci of coagulative tumor necrosis. 
Ovarian monodermal teratomas of carcinoid 
type, including insular, trabecular, strumal and 
mucinous carcinoids, have been the subject of 
several studies during the last 3 decades, 
resulting in a well-established classification 
system [5-9]. However, there is no available 
data on aggressive histological features of 
ovarian carcinoid tumors. We herein report for 
the first time a case of primary ovarian carci-
noid tumor with aggressive histological fea-
tures and an unusual immunophenotype.
Case presentation
A 21-year-old Korean woman was referred to 
the Department of Obstetrics and Gynecology, 
Samsung Medical Center (Seoul, Republic of 
Korea), presenting with a palpable abdominal 
mass. Physical and pelvic examination revealed 
a large pelvic mass, which was the size of an 
adult head. Her past medical history was unre-
markable. Hematological profile revealed 
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hemoglobin of 12.0 g/dL with normal leukocyte 
and platelet counts. Serum levels of cancer 
antigen (CA) 125 (44.8 U/mL) and lactate dehy-
drogenease (2,396.0 IU/L) were increased, 
whereas those of β-human chorionic gonado-
tropin, carcinoembryonic antigen and CA 19-9 
were within normal limits. Computed tomo-
graphic (CT) scan of the abdomen revealed a 
large, necrotic solid mass in the left ovary 
(Figure 1A). Tumor involvement was not 
observed in the uterus, right ovary and lymph 
nodes; and peritoneal seeding and hematoge-
nous metastasis were absent. Based on imag-
ing and laboratory findings, both germ cell 
tumor and malignant epithelial tumor were sus-
pected. A left salpingo-oophorectomy was per-
formed. The postoperative course was unevent-
ful, and the patient left the hospital 5 days 
later. Four months after surgery, abdominal CT 
scan showed no evidence of recurrence. Whole 
body positron emission tomographic scan 
showed no abnormal hypermetabolic lesion. 
Pathologic findings
Grossly, the left adnexa showed a large, vague-
ly lobulated ovarian tumor measuring 
22×15×13 cm. There were no gross areas of 
capsular breach. On serial sectioning, the left 
ovary was completely replaced by the tumor, 
which was whitish yellow, predominantly solid 
with necrotic areas of varying size. The solid 
component was a conglomeration of multiple, 
relatively well-circumscribed nodules (Figure 
Figure 1. Clinicopathological findings of primary “atypical” ovarian carcinoid. A. CT scan revealed a huge, solid 
adnexal mass. B. Grossly, conglomeration of relatively well-circumscribed, whitish yellow, solid nodules surrounded 
central areas of tumor necrosis. C. Histologically, organoid and trabecular growth patterns typical of neuroendocrine 
tumor were evident. D. However, some areas displayed a loss of “neuroendocrine” growth pattern. E. The solid 
growth pattern was associated with mild nuclear pleomorphism with chromatin condensation, apoptotic bodies and 
punctate necrosis. F. Mitotic figures (yellow circles) were frequently identified. Three mitotic figures were detected in 
a single high-power field. G. A few foci of extensive coagulative tumor necrosis were also noted. Immunohistochemi-
cally, the tumor tissue was positive for H. CD56 and I. β-catenin. J. In particular, the tumor cells exhibited strong, 
uniform nuclear β-catenin immunoreactivity.
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1B). No normal ovarian tissue was identified in 
the left adnexal mass. The left salpinx was 
grossly unremarkable. Histologically, the tumor 
displayed a readily identifiable neuroendocrine 
growth pattern that consists of various archi-
tectural types. Tumor cells were arranged in a 
mainly trabecular (Figure 1C) and nested pat-
tern, and had a polygonal contour, with ample 
amounts of granular cytoplasm. Their nuclei 
were centrally located, monotonous and round, 
without marked nuclear pleomorphism or 
prominent nucleoli. However, in some areas, 
the tumor exhibited a solid growth pattern 
(Figure 1D), associated with mild nuclear pleo-
morphism, chromatin condensation and multi-
ple foci of punctate necrosis (Figure 1E). 
Furthermore, mitotic figures were recognized in 
8 per 10 high-power fields (Figure 1F). A few 
large foci coagulative tumor necrosis were obvi-
ous (Figure 1G). The ovarian surface or left sal-
pinx was not involved. Immunohistochemically, 
the tumor cells showed strong membranous 
reactivity for CD56 (Figure 1H) and synaptophy-
sin, but they were negative for OCT4, CD117, 
D2-40, inhibin-α and calretinin. The tumor cells 
were also positive for β-catenin (Figure 1I), with 
uniform and strong nuclear staining of individu-
al tumor cells (Figure 1J).
Discussion
According to the WHO classification of pulmo-
nary tumor [10], carcinoid tumors are charac-
terized by growth patterns that suggest neuro-
endocrine differentiation, including organoid, 
insular, trabecular, palisading, ribbon and 
rosette-like arrangements. Individual tumor 
cells have uniform cytologic features with mod-
erate eosinophilic, finely granular cytoplasm 
and nuclei with a finely granular chromatic pat-
tern. Pulmonary carcinoid tumors are classified 
as typical or atypical, depending on the mitotic 
activity and the presence of necrosis. Typical 
carcinoid is defined as a carcinoid tumor with < 
2 mitoses per 10 high-power fields (2 mm2) and 
lacking necrosis. In contrast, atypical carcinoid 
is defined as a carcinoid tumor with 2-10 mito-
sis per 10 high-power fields and/or foci of 
necrosis. There are no established histological 
criteria for discriminating between typical and 
atypical ovarian carcinoid tumors. Since the 
incidence of ovarian carcinoid is very low with 
no reported cases of ovarian carcinoid with 
aggressive histological features, there was no 
previous necessity for establishing criteria for 
atypical carcinoid tumor of the ovary. According 
to the WHO classification of pulmonary carci-
noid tumor, it is reasonable to classify the cur-
rent case as “atypical” carcinoid. The presence 
of large areas of coagulative tumor necrosis 
favors a neuroendocrine carcinoma rather than 
atypical carcinoid, but necrosis per se is not 
diagnostic of neuroendocrine carcinoma [11]. 
Necrosis may also occur extensively in atypical 
carcinoid tumors [10, 12, 13]. Furthermore, 
tumor cells did not exhibit obvious nuclear pleo-
morphism or prominent nucleoli. Despite thor-
ough searches, mitotic figures were < 10 per 
10 high-power fields. The distinction of atypical 
carcinoid from other neuroendocrine tumors 
should be based on morphological parameters 
that include the amount and pattern of necro-
sis, cell size, amount of cytoplasm, nuclear 
chromatin and degree of pleomorphism, nucle-
oli, and most importantly, the mitotic rate [14]. 
Due to the absence of diagnostic criteria, pri-
mary ovarian atypical carcinoid tumors might 
be underdiagnosed and often unrecognized. 
Additional reports are necessary to better 
understand the nature of ovarian atypical 
carcinoid.
Interestingly, the tumor cells displayed uniform, 
strong nuclear immunoreactivity for β-catenin. 
Nuclear accumulation of β-catenin is reported 
in pulmonary neuroendocrine and gastrointes-
tinal carcinoid tumors [15, 16]. Pelosi and col-
leagues [15] reported that the nuclear accumu-
lation of β-catenin is present exclusively in 
pulmonary small- and large-cell neuroendo-
crine carcinoma and atypical carcinoid tumors, 
whereas normal and hyperplastic neuroendo-
crine cells have uniform membranous β-ca- 
tenin. They found that an aberrant β-catenin 
staining pattern is an independent predictor of 
lymph node metastasis in patients with atypi-
cal carcinoid tumor, and suggest a possible role 
for the impaired intracellular β-catenin signal-
ing apparatus in the development and progres-
sion of pulmonary neuroendocrine tumors. In 
contrast, Su and colleagues [16] reported that 
even though the nuclear accumulation of 
β-catenin occurs in gastrointestinal carcinoid 
tumors, β-catenin and APC gene mutation is 
absent in all cases with nuclear β-catenin 
expression, suggesting that β-catenin mutation 
is less likely to contribute to the pathogenesis 
of gastrointestinal carcinoid tumors. To the 
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best of our knowledge, we reported for the first 
time the nuclear accumulation of β-catenin in 
primary ovarian carcinoid tumor. Tumor involve-
ment of lymph nodes could not be ruled out 
since we did not conduct pelvic lymphadenec-
tomy; and close follow-up is crucial based on 
the previous observation of Pelosi and col-
leagues [15]. More studies are required to clar-
ify the role of β-catenin and its genetic altera-
tion in the tumorigenesis and progression of 
ovarian carcinoid tumors.
In summary, we demonstrated the first case of 
primary ovarian carcinoid tumor with aggres-
sive histological features, including loss of neu-
roendocrine growth pattern, increased mitotic 
activity and large areas of coagulative tumor 
necrosis. Our case may be classified as “atypi-
cal” carcinoid according to the WHO classifica-
tion of pulmonary carcinoid tumor. The rarity 
poses a challenge to the diagnosis, histological 
subclassification and assessment of clinical 
outcome. Additional reports are clearly neces-
sary to better understand the nature of ovarian 
“atypical” carcinoid. We also showed for the 
first time the nuclear accumulation of β-catenin 
in ovarian carcinoid tumor cells, suggestive of 
its role in the tumorigenesis or the develop-
ment of its aggressive histological phenotype.
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